Pharmanutra S.p.A. (BIT:PHN)

Market Cap	515.69M
Revenue (ttm)	116.15M
Net Income (ttm)	16.61M
Shares Out	9.60M
EPS (ttm)	1.73
PE Ratio	31.07
Forward PE	24.23
Dividend	1.00 (1.86%)
Ex-Dividend Date	May 5, 2025

Volume	5,341
Average Volume	7,570
Open	53.90
Previous Close	53.70
Day's Range	51.20 - 53.90
52-Week Range	44.85 - 61.20
Beta	0.30
RSI	58.59
Earnings Date	Sep 8, 2025

About Pharmanutra

Pharmanutra S.p.A., a pharmaceutical and nutraceutical company, researches, designs, develops, and markets nutritional supplements and medical devices in Italy, Europe, the Middle East, South America, Far East, and internationally. The company produces and markets pharmaceuticals, medical devices, OTC products, and nutraceuticals for pediatric sector; and produces and distributes raw materials and active ingredients for the food, pharmaceutical, and dietary supplement industries. It also sells machinery and instruments for measuring body bioimp...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2003
• Employees: 118
• Stock Exchange: Borsa Italiana
• Ticker Symbol: PHN

Financial Performance

In 2024, Pharmanutra's revenue was 116.15 million, an increase of 15.33% compared to the previous year's 100.71 million. Earnings were 16.61 million, an increase of 29.43%.